Cargando…
Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders
The Farnesoid X receptor (FXR) is a nuclear receptor which is activated by bile acids. Bile acids function in solubilization of dietary fats and vitamins in the intestine. In addition, bile acids have been increasingly recognized to act as signaling molecules involved in energy metabolism pathways,...
Autores principales: | Appelman, Monique D., van der Veen, Suzanne W., van Mil, Saskia W. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503269/ https://www.ncbi.nlm.nih.gov/pubmed/34646233 http://dx.doi.org/10.3389/fendo.2021.729828 |
Ejemplares similares
-
Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011) -
The Multiplicity of Post-Translational Modifications in Pro-Opiomelanocortin-Derived Peptides
por: Yasuda, Akikazu, et al.
Publicado: (2013) -
Stat3 role in the protective effect of FXR Agonist in parenteral nutrition-associated cholestasis
por: Ghosh, Swati, et al.
Publicado: (2023) -
FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis
por: van Golen, Rowan F., et al.
Publicado: (2018) -
BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination
por: Jung, Hyunkyung, et al.
Publicado: (2020)